A pan-cancer analysis revealed that compared to normal tissues, significantly elevated mRNA expression levels of SYNGR2 were observed in 26 cancers, including BLCA, BRCA, CESC, and other tumor tissues. Here, SYNGR2 is linked to neoplasm.